Cargando…

Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016

BACKGROUND: The End Tuberculosis (TB) Strategy aims to achieve 90% reduction of deaths due to TB by 2030, compared with 2015. Mortality due to tuberculosis in Mali was 13 per 100,000 inhabitants in 2014 and 11 per 100,000 inhabitants in 2017. Risk factors for death are not known. The objective of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballayira, Yaya, Yanogo, Pauline Kiswendsida, Konaté, Bakary, Diallo, Fadima, Sawadogo, Bernard, Antara, Simon, Méda, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132441/
https://www.ncbi.nlm.nih.gov/pubmed/34006238
http://dx.doi.org/10.1186/s12889-021-10986-4
_version_ 1783694915006365696
author Ballayira, Yaya
Yanogo, Pauline Kiswendsida
Konaté, Bakary
Diallo, Fadima
Sawadogo, Bernard
Antara, Simon
Méda, Nicolas
author_facet Ballayira, Yaya
Yanogo, Pauline Kiswendsida
Konaté, Bakary
Diallo, Fadima
Sawadogo, Bernard
Antara, Simon
Méda, Nicolas
author_sort Ballayira, Yaya
collection PubMed
description BACKGROUND: The End Tuberculosis (TB) Strategy aims to achieve 90% reduction of deaths due to TB by 2030, compared with 2015. Mortality due to tuberculosis in Mali was 13 per 100,000 inhabitants in 2014 and 11 per 100,000 inhabitants in 2017. Risk factors for death are not known. The objective of this study was to determine the time and risk factors for death in pulmonary TB patients with positive microscopy. METHODS: We conducted a retrospective cohort study from October to December 2016 in Commune VI of Bamako. Smear positive cases pulmonary tuberculosis from 2011 to 2015 were included. We reviewed the treatment registers and collected sociodemographic, clinical, biological and therapeutic data. Median time to death and hazard ratio (HR) were estimated by the Kaplan-Meier method and a Cox regression model, respectively. RESULTS: In total, we analysed 1362 smear positive cases of pulmonary TB including 104 (8%) HIV positive and 90 (7%) deaths. The mean age was 36 ± 13 years, the sex ratio of males to females was 2:1. Among the deaths, 48 (53%) occurred during the first 2 months of treatment. Age ≥ 45 years (HR 2.09 95% CI [1.35–3.23]), weight <  40 kg (HR 2.20 95% CI [1.89–5.42]), HIV unknown status (HR 1.96, 95% CI [1.04–3.67]) and HIV-positive (HR 7.10 95% CI [3.53–14.26]) were significantly associated with death. CONCLUSIONS: The median time to death was 2 months from the start of treatment. Independent risk factors for death were age ≥ 45 years, weight <  40 kg, unknown and positive HIV status. We recommend close monitoring of patients over 45 years, HIV testing in those with unknown status, an adequate care for positive HIV status, as well as a nutritional support for those with weight below 40 kg during the intensive phase of TB treatment.
format Online
Article
Text
id pubmed-8132441
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81324412021-05-19 Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016 Ballayira, Yaya Yanogo, Pauline Kiswendsida Konaté, Bakary Diallo, Fadima Sawadogo, Bernard Antara, Simon Méda, Nicolas BMC Public Health Research BACKGROUND: The End Tuberculosis (TB) Strategy aims to achieve 90% reduction of deaths due to TB by 2030, compared with 2015. Mortality due to tuberculosis in Mali was 13 per 100,000 inhabitants in 2014 and 11 per 100,000 inhabitants in 2017. Risk factors for death are not known. The objective of this study was to determine the time and risk factors for death in pulmonary TB patients with positive microscopy. METHODS: We conducted a retrospective cohort study from October to December 2016 in Commune VI of Bamako. Smear positive cases pulmonary tuberculosis from 2011 to 2015 were included. We reviewed the treatment registers and collected sociodemographic, clinical, biological and therapeutic data. Median time to death and hazard ratio (HR) were estimated by the Kaplan-Meier method and a Cox regression model, respectively. RESULTS: In total, we analysed 1362 smear positive cases of pulmonary TB including 104 (8%) HIV positive and 90 (7%) deaths. The mean age was 36 ± 13 years, the sex ratio of males to females was 2:1. Among the deaths, 48 (53%) occurred during the first 2 months of treatment. Age ≥ 45 years (HR 2.09 95% CI [1.35–3.23]), weight <  40 kg (HR 2.20 95% CI [1.89–5.42]), HIV unknown status (HR 1.96, 95% CI [1.04–3.67]) and HIV-positive (HR 7.10 95% CI [3.53–14.26]) were significantly associated with death. CONCLUSIONS: The median time to death was 2 months from the start of treatment. Independent risk factors for death were age ≥ 45 years, weight <  40 kg, unknown and positive HIV status. We recommend close monitoring of patients over 45 years, HIV testing in those with unknown status, an adequate care for positive HIV status, as well as a nutritional support for those with weight below 40 kg during the intensive phase of TB treatment. BioMed Central 2021-05-18 /pmc/articles/PMC8132441/ /pubmed/34006238 http://dx.doi.org/10.1186/s12889-021-10986-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ballayira, Yaya
Yanogo, Pauline Kiswendsida
Konaté, Bakary
Diallo, Fadima
Sawadogo, Bernard
Antara, Simon
Méda, Nicolas
Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016
title Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016
title_full Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016
title_fullStr Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016
title_full_unstemmed Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016
title_short Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016
title_sort time and risk factors for death among smear-positive pulmonary tuberculosis patients in the health district of commune vi of bamako, mali, 2016
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132441/
https://www.ncbi.nlm.nih.gov/pubmed/34006238
http://dx.doi.org/10.1186/s12889-021-10986-4
work_keys_str_mv AT ballayirayaya timeandriskfactorsfordeathamongsmearpositivepulmonarytuberculosispatientsinthehealthdistrictofcommuneviofbamakomali2016
AT yanogopaulinekiswendsida timeandriskfactorsfordeathamongsmearpositivepulmonarytuberculosispatientsinthehealthdistrictofcommuneviofbamakomali2016
AT konatebakary timeandriskfactorsfordeathamongsmearpositivepulmonarytuberculosispatientsinthehealthdistrictofcommuneviofbamakomali2016
AT diallofadima timeandriskfactorsfordeathamongsmearpositivepulmonarytuberculosispatientsinthehealthdistrictofcommuneviofbamakomali2016
AT sawadogobernard timeandriskfactorsfordeathamongsmearpositivepulmonarytuberculosispatientsinthehealthdistrictofcommuneviofbamakomali2016
AT antarasimon timeandriskfactorsfordeathamongsmearpositivepulmonarytuberculosispatientsinthehealthdistrictofcommuneviofbamakomali2016
AT medanicolas timeandriskfactorsfordeathamongsmearpositivepulmonarytuberculosispatientsinthehealthdistrictofcommuneviofbamakomali2016